Palatrigine, formerly known as BW A256C, is a chemically novel agent which exhibits in a single molecule both angiotensin converting enzyme (ACE) inhibition and beta-adrenoceptor-blocking properties. References: Allan G, Donoghue S, Follenfant MJ, Sawyer DA. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents. Br J Pharmacol. 1986 Jun;88(2):333-43. PubMed PMID: 3730698; PubMed Central PMCID: PMC1916834.

纯度：≥98%

CAS：98410-36-7